About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Psoriasis Therapy Reduces Risk of Heart Diseases

by Sushma Rao on April 27, 2018 at 10:19 AM
 Psoriasis Therapy Reduces Risk of Heart Diseases

Some common psoriasis (PSO)-a chronic inflammatory skin disease treatments may decrease your chances of experiencing a heart attack. The treatments were found to not only reduce the volume of the heart plaque, but also the plaque becomes less inflammatory over time reducing heart attack risk.

It is the first-in-human observational study demonstrating that treating remote inflammation in the body can modulate coronary disease. The study was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions 2018 by Research Fellow Youssef Elnabawi from the National Heart, Lung, and Blood Institute in Bethesda, Maryland.

Advertisement


In the United States, there are about 150,000 new cases of PSO every year, and the disease affects more than 7.5 million people (AAD). It is associated with an accelerated risk of myocardial infarction (Gefland JM, et al., JAMA 2006), and has increased risk for atherogenesis, which is the development of plaque within the walls of blood vessels (Lerman JB, et al., Circ 2017). For the first time, recent evidence demonstrated a significant reduction in adverse cardiovascular events targeting interleukin-1 beta (IL1B), a cytokine that is central to the inflammatory response (Ridker P et al., NEJM, 2017).

The authors worked to identify if treatment of the inflammatory skin disease potentially affected coronary plaque. Anti-tumor necrosis factor (TNF) agents are commonly used, biologic, and FDA-approved immunomodulatory treatment options for PSO. More than 80 consecutive patients were stratified by biologic treatment (predominantly anti-TNF; n=57) and non-biologic treatment (n= 27). Non-calcified burden (NCB), plaque volume (PV), and maximal artery stenosis in the proximal vessels (diameter>2mm) were blindly assessed based on coronary CT angiography using dedicated software.
Advertisement

The patients were middle-aged and at low cardiovascular risk by traditional risk scores. At one-year, the plaque volume in the biologic treated group decreased by 40 percent (p=0.002), a finding not observed in those without treatment (p=0.04). Trends in NCB and maximal stenosis were significant and consistent with PV in both groups. Furthermore, change in PV was also positively associated with a change in IL1B (β=0.56, p=0.03), even after adjustment for traditional cardiovascular risk factors and statin use.

"To see a reduction in coronary plaque after just one year of biologic therapy alone is incredible and very assuring. It's the first time we're seeing treatment of a skin disease with biologic therapy have an impact specifically on plaque in the coronary," said Nehal N. Mehta, MD MSCE FAHA, the Principal Investigator of the study from the National Heart, Lung, and Blood Institute. "Our study results further emphasize the importance of patients maintaining and treating psoriasis to decrease the risks of adverse cardiovascular events occurring. This also opens the door for us to look at other disease states and see how anti-inflammatory therapy options could impact coronary plaque over time."

The authors of the study note that future, randomized studies are warranted to confirm these observational findings and to better understand how treatment with anti-inflammatory medications modulates coronary plaque volume over time.



Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Heart Disease News

How Hot Flashes and Cardiovascular Risk Factors Tied-Up?
Midlife women approaching menopause experience hot flashes which are linked to increased systemic inflammation, a risk factor for heart diseases.
Etripamil Nasal Spray - Quick & Simple Fix for High Heartrate
Patients with tachycardia (fast heart rate) can quickly return to normal heart rhythm with a self-administered etripamil nasal spray.
Doctors Urge Action on Rising Heart Disease Burden
Every year on September 29, World Heart Day is observed to promote awareness of heart-related diseases and seek solutions for heart disease prevention and management.
Global Heart Failure Cases Projected to Exceed 16 Million by 2032
While heart failure can affect both genders, it is more commonly observed in men and is more prevalent in the elderly population.
Traumatic Brain Injury - Unacknowledged Risk Factor in Cardiovascular Diseases
Traumatic brain injury survivors (military, sports personnel) are at higher risk of cardiovascular and cognitive dysfunction in relative to general population.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Psoriasis Therapy Reduces Risk of Heart Diseases Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests